BRIAN L. STROM, B.S.; PAUL D. STOLLEY, M.D., M.P.H.; TORREY C. BROWN, M.D., F.A.C.P.
Antisubstitution laws are the state laws that require the pharmacist to dispense exactly the brand of drug prescribed by the physician. Repeal of these laws may result in saving a significant amount of money for consumers but may involve additional costs in terms of quality of health care delivery. Issues of economics, drug-product equivalence, drug-product quality, and physicians' prerogatives are discussed. The state of Maryland has recently enacted a partial repeal of its antisubstitution law. Maryland's law is evaluated in terms of these issues and the different savings and costs that the law could produce for consumers. A modified version of this law is proposed as a model for all states.
BRIAN L. STROM, PAUL D. STOLLEY, TORREY C. BROWN. Antisubstitution Law Controversy—A Solution?. Ann Intern Med. 1974;81:254–258. doi: 10.7326/0003-4819-81-2-254
Download citation file:
Published: Ann Intern Med. 1974;81(2):254-258.
Healthcare Delivery and Policy, Prevention/Screening.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use